Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPLACIZUMAB vs CAPSAICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPLACIZUMAB vs CAPSAICIN: Safety Overview

Metric CAPLACIZUMAB CAPSAICIN
Total FAERS Reports 145 1,719
Deaths Reported 34 59
Death Rate 23.4% 3.4%
Hospitalizations 53 258
Average Patient Age 53.0 yrs 55.2 yrs
% Female Patients 51.2% 57.5%
FDA Approval Date N/A Nov 16, 2009
Manufacturer Genzyme Corporation Nufabrx LLC
Route N/A TOPICAL
Marketing Status N/A Prescription